Skip to main content
. Author manuscript; available in PMC: 2022 Feb 15.
Published in final edited form as: Clin Cancer Res. 2021 Jun 11;27(16):4587–4598. doi: 10.1158/1078-0432.CCR-21-0180

Figure 5.

Figure 5.

Impact of cetuximab treatment on tumor volume in mouse xenograft models derived from SW48 isogenic clones carrying select RAS mutations. (A) Fold change in size of xenograft at the end of 21 days of cetuximab treatment relative to control and (B) tumor size during 21-day treatment cycle with cetuximab or control (mean +/− standard error) for each tested variant.